Changes in the localization of ileal P-glycoprotein induced by intestinal ischemia/reperfusion

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 3, 2011, Pages 408-414

  Takizawa, Yusuke ^a   Kishimoto, Hisanao ^a   Kitazato, Takuya ^a   Tomita, Mikio ^a   Hayashi, Masahiro ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Cytokine; Intestinal ischemia reperfusion; Multidrug resistance 1b; Multidrug resistance 2; Nitric oxide; P glycoprotein

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALKALINE PHOSPHATASE; GLYCOPROTEIN P; NITRATE; NITRITE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASOLATERAL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE; ILEUM; INTERLEUKIN 1BETA GENE; INTESTINE BRUSH BORDER MEMBRANE; INTESTINE ISCHEMIA; MALE; MULTIDRUG RESISTANCE 1A GENE; MULTIDRUG RESISTANCE 1B GENE; MULTIDRUG RESISTANCE 2 GENE; NONHUMAN; NUCLEAR FACTOR KAPPA B GENE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REPERFUSION INJURY; SISTER P GLYCOPROTEIN GENE; TUMOR NECROSIS FACTOR ALPHA GENE;

ANIMALS; BIOLOGICAL TRANSPORT; CYTOKINES; ILEUM; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION MEDIATORS; INTESTINAL MUCOSA; ISCHEMIA; MALE; NITRIC OXIDE; ORGAN TRANSPLANTATION; P-GLYCOPROTEIN; RATS; RATS, WISTAR; REPERFUSION; RNA, MESSENGER;

EID: 79952322110     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.408     Document Type: Article

References (26)

1. Hyde S. C., Emsley P., Hartshorn M. J., Mimmack M. M., Gileadi U., Pearce S. R., Gallagher M. P., Gill D. R., Hubbard R. E., Higgins C. F., Nature (London), 346, 362-365 (1990).
2. Dean M., Hamon Y., Chimini G. T., J. Lipid Res., 42, 1007-1017 (2001).
3. Russel F. G., Masereeuw R., van Aubel R. A., Annu. Rev. Physiol., 64, 563-594 (2002).
4. Szakács G., Váradi A., Ozvegy-Laczka C., Sarkadi B., Drug Discov. Today, 13, 379-393 (2008).
5. Leslie E. M., Deeley R. G., Cole S. P., Toxicol. Appl. Pharmacol., 204, 216-237 (2005).
6. Nagira M., Tomita M., Mizuno S., Kumata M., Ayabe T., Hayashi M., Drug Metab. Pharmacokinet., 21, 230-237 (2006).
7. Tomita M., Takizawa Y., Kishimoto H., Hayashi M., Drug Metab. Pharmacokinet., 23, 356-363 (2008).
8. Tomita M., Takizawa Y., Kishimoto H., Hayashi M., J. Pharm. Pharmacol., 61, 1319-1324 (2009).
9. Tomita M., Kishimoto H., Takizawa Y., Hayashi M., Drug Metab. Pharmacokinet., 24, 428-437 (2009).
10. Iida A., Tomita M., Idota Y., Takizawa Y., Hayashi M., Drug Metab. Pharmacokinet., 21, 424-428 (2006).
11. Stieger B., Murer H., Eur. J. Biochem., 135, 95-101 (1983).
12. Hsing S., Gatmaitan Z., Arias I. M., Gastroenterology, 102, 879-885 (1992).
13. Orsenigo M. N., Tosco M., Esposito G., Faelli A., Anal. Biochem., 144, 577-583 (1985).
14. Kramer H. J., Backer A., Kruck F., Clin. Chim. Acta, 50, 13-18 (1974).
15. Ogasawara A., Kume T., Kazama E., Drug Metab. Dispos., 35, 410-418 (2007).
16. Kamiyama E., Nakai D., Mikkaichi T., Okudaira N., Okazaki O., Life Sci., 86, 52-58 (2010).
17. Troutman M. D., Thakker D. R., Pharm. Res., 20, 1210-1224 (2003).
18. Ziemann C., Burkle A., Kahl G. F., Ernst K. I. H., Carcinogenesis, 20, 407-414 (1999).
19. Bauer B., Hartz A. M., Miller D. S., Mol. Pharmacol., 71, 667-675 (2007).
20. Lowenstein C. J., Cardiovasc. Res., 75, 240-246 (2007).
21. Skinn A. C., MacNaughton W. K., Am. J. Physiol. Gastrointest. Liver Physiol., 289, G739-G744 (2005).
22. Ji B., Ito K., Sekine S., Tajima A., Horie T., Free Radic. Biol. Med., 37, 1718-1729 (2004).
23. Kubitz R., Wettstein M., Warskulart U., Häussinger D., Gastroenterology, 116, 401-410 (1999).
24. Yano K., Sekine S., Nemoto K., Fuwa T., Horie T., Biochem. Pharmacol., 80, 533-539 (2010).
25. Gonzalez J. E., DiGeronimo R. J., Arthur D. E., King, J. M., Free Radic. Biol. Med., 47, 1561-1569 (2009).
26. Kausalya P. J., Amasheh S., Günzel D., Wurps H., Müller D., Frommr M., Hunziker W., J. Clin. Invest., 116, 878-891 (2006).